The term "Bull Pharma" has arisen recently, sparking a heated discussion surrounding specific pharmaceutical companies . Allegations of unethical marketing strategies , unreasonable drug rates, and a suspected disregard for patient safety have triggered increasing criticism from watchdogs, consumer